The AIG, Illumina, Alphabet and Orient Life-backed cell therapy developer priced its shares at the bottom of the range to raise $70.6m.

Business financial tool marketplace Fundera has been bought by NerdWallet after raising some $15m from investors including Susquehanna Growth Equity.

Genetic testing company Prenetics leveraged a UK-based subsidiary to buy Oxsed having piloted the latter's rapid coronavirus screening system.

Intel is set to buy Stanford University-backed machine learning optimisation business SigOpt, which had raised at least $8.6m in funding.

Ping An's financial services spinoff raised $2.36bn in a US initial public offering that represented an exit for Bank of China, Cofco, SBI and several investment banks.

Nestlé bought the healthy meal kit delivery service three years after leading its series C round, in a deal that could reach $1.5bn with earnouts.

REA Group and parent company News Corp are reportedly paying $70m for a controlling stake in online real estate portal and portolio company Elara Group.

In 2017, property listing startup Hipflat raised an undisclosed amount from Japan-listed internet company Aucfan

Novo, Bristol Myers-Squibb and Merck Group scored exits as the fibrosis and cancer drug developer priced its shares in the middle of the IPO's range.

Spun out of University of Louisville, Koligo Therapeutics has already launched its first cell therapy product and aims to commercialise a treatment for covid-19.